|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Florida
2 Malcom Randall Veterans Affairs Medical Center
3 College of Medicine, University of Florida
4 Veterans Affairs Medical Center
* To whom correspondence should be addressed. E-mail: scarpace{at}ufl.edu.
We used rAAV-mediated gene delivery to overexpress a mutant of rat leptin yielding a protein that acts as a neutral leptin receptor antagonist. The long-term consequences of this overexpression on body weight homeostasis and physical activity, as assessed by voluntary wheel running (WR), were determined in F344xBN rats. Leptin antagonist overexpression was confirmed by examination of mRNA levels in the hypothalamus. Food consumption and body weight gain was exacerbated in the antagonist group during both chow and high-fat feeding periods over the 192 day experiment. In a second experiment, a lower dose of antagonist vector was used that resulted in no change in food consumption but still increased body weight. The degree of antagonist overexpression was sufficient to partially block STAT3 phosphorylation due to administration of an acute sub-maximal dose of leptin. Rats were provided free access to running wheels for 4 days during both the chow and high-fat feeding periods. With both antagonist doses and during both chow and high-fat feeding, WR was substantially less with antagonist overexpression. In contrast, when leptin was overexpressed in the hypothalamus, WR activity was increased by greater than 2-fold. At death, adiposity and serum leptin levels were greater in the antagonist group. These data indicate that sub-maximal central leptin receptor blockade promotes obesity and diminishes WR activity. These findings underscore the critical role of unrestrained leptin receptor activity in long-term energy homeostasis, and suggest that even minor disruption of leptin receptor function can promote obesity.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |